pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Biotech is a pharma organization headquartered in TEL AVIV, DE. It trades on NYSE under ticker TEVA. Primary therapeutic focus areas include Asthma, Multiple Sclerosis, Pain, Crohn's Disease, Seasonal Allergic Rhini
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 473
- Drugs
- 447
- Patents
- 454
Norethindrone/Ethinyl Estradiol
Phase 1 · small molecule · Bioequivalence
Norethindrone/Ethinyl Estradiol for Bioequivalence is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code R06-1188
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Teva Pharma GmbH
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Bioequivalence
- Status
- completed
- Trials
- 1